Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status

BACKGROUND/AIMS: Antiviral therapy (AVT) reduces the risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B (CHB). This multicenter retrospective study investigated the effects of AVT and hepatitis B virus (HBV)-related factors on the risk of HCC development in a coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi Na, Hwang, Seong Gyu, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Han, Kwang-Hyub, Kim, Seung Up, Ahn, Sang Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430437/
https://www.ncbi.nlm.nih.gov/pubmed/30602075
http://dx.doi.org/10.5009/gnl18204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430437/
https://www.ncbi.nlm.nih.gov/pubmed/30602075
http://dx.doi.org/10.5009/gnl18204

Ejemplares similares